Report a problem

28.6m / 27.6m

More Details..

	OR

Email Id:	(Required) (Required)
Password:	*(Required)
	Remember Me	Reset Password?
	Note: Please enter emailid to receive instructions to reset password.

	Not A Member Yet ? Sign Up

Email Id:	(Required) (Required)
Password:	*(Required)
	Remember Me	Reset Password?
	Note: Please enter emailid to receive instructions to reset password.

Name	*(Required)
Email	*(Required)
Telephone	(Required) (Invalid number !)
Subject	*(Required)
Comment	*(Required)


	Send

Dhara Patwa

KR Choksey

Bulls Eye

Dhara Patwa, Vaibhav Chowdhry

02 Nov 2017
Dhara Patwa, Vaibhav Chowdhry

02 Nov 2017
Dhara Patwa, Vaibhav Chowdhry

02 Nov 2017
Dhara Patwa, Vaibhav Chowdhry

02 Nov 2017
Dhara Patwa, Vaibhav Chowdhry

23 Nov 2017
Dhara Patwa, Vaibhav Chowdhry

23 Nov 2017
Vaibhav Chowdhry, Dhara Patwa

20 Dec 2017

Dhara Patwa

Investment Style:

I am a sell side analyst and largely track Pharma sector with more than 3+ years of experience in the global pharma sector. I have keen interest in tracking therapies such as oncology, autoimmune disorders and neurology. My recommendations are based on fundamentals studies and are based on long term investing prospective.

Research Reports :

Indoco Remedies Target: Rs 228.00
31 May 18

Result Update

Net Sales stood at INR 2,588 Mn which was down by 2.5%

KR Choksey

Granules India Target: Rs 98.00
29 May 18

Result Update

Net Sales stood at INR 5,038 Mn which was up by 41.8% y-o-y and 22.7% q-o-q.

KR Choksey

Sun Pharma Target: Rs 539.00
29 May 18

Result Update

Net Sales stood at INR 67,110 Mn which was down by 1.7% y-o-y but was marginally up by 1.7% q-o-q,

KR Choksey

Dr Reddys Labs Target: Rs 2103.00
24 May 18

Result Update

Dr Reddy’s Labs reported Q4FY18 revenue of INR 35,349 mn which degrew 7.12% Q-o-Q but marginally grew by 1.04% Y-o-Y.

KR Choksey

Cipla Target: Rs 607.00
23 May 18

Result Update

Net Sales stood at INR 34,958 Mn which was up by 0.25% y-o-y but was down 8.83% q-o-q.

KR Choksey

Lupin Target: Rs 785.00
17 May 18

Result Update

Lupin reported Q4FY18 revenue of INR 39,784

KR Choksey

Sun Pharma Target: Rs 633.00
23 Mar 18

Event Update

USFD Aapprovl of ILUMYA (tildrakizumab) for the treatment of moderate-to-severe plaque psoriasis

KR Choksey

Vivimed Labs Target: Rs 134.00
05 Mar 18

Result Update

Vivimed Labs Limited (VIVIMEDLAB), is an integrated pharma player having a strong presence across the value chain by leveraging its proven expertise in the realm of chemistry.

KR Choksey

Vivimed Labs Target: Rs 134.00
05 Mar 18

Sales Note

Vivimed Labs Limited (VIVIMEDLAB), is an integrated pharma player having a strong presence across the value chain by leveraging its proven expertise in the realm of chemistry

KR Choksey